Analyst Ratings for CytomX Therapeutics (CTMX) [Neutrals]

CTMX Rating Summary

CTMX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CTMX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $11.92 (+77.9%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 78%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/22/2020 Guggenheim Etzer Darout Downgrade Neutral
(Buy)
N/A
(N/A)
6.94
(6.70)
-3.46% Details
2/27/2019 Citi
» Updated 9/15/2020
Mohit Bansal Downgrade Neutral
(Buy)
8.50
(11.00)
19.16
(6.70)
-65.03% Details
Like CTMX Ratings? Also take a look at R, INCY, CRVS, AUTL

CTMX Ratings News